Russell Frank Company’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-296
Closed -$29K 3164
2015
Q1
$29K Buy
+296
New +$29K ﹤0.01% 2854
2013
Q4
Sell
-2,575
Closed -$163K 3353
2013
Q3
$163K Sell
2,575
-79,614
-97% -$5.04M ﹤0.01% 2825
2013
Q2
$3.45M Buy
+82,189
New +$3.45M 0.01% 1467